Fortis Capital Management LLC

Position in LLY — ELI LILLY & Co

CIK 1802167 BELLEVUE, WA

Position in LLY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$11,167,893

+$3,038,046 QoQ

Shares Held

9,311

+5.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.81%

of 13F equity value

Holder Rank

#1,198

of 4,605 holders

Holding Since

Sep 2020

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fortis Capital Management LLC holds $16,796,483 across 6 Drug Manufacturers - General names. LLY ranks #1 (66.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	9,311	$11,167,893
2	ABBV	AbbVie Inc.	8,042	$2,023,688
3	JNJ	Johnson & Johnson	6,812	$1,730,043
4	AMGN	Amgen Inc	3,739	$1,353,966
5	NVS	Novartis AG	1,665	$260,938
6	MRK	Merck & Co., Inc.	2,023	$259,955

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,167,893	9,311	+5.3%	Shares	Sole	2026-08-13
2026-03-31	$8,129,847	8,839	+1.3%	Shares	Sole	2026-05-12
2025-12-31	$9,376,583	8,725	+5.5%	Shares	Sole	2026-02-13
2025-09-30	$6,307,721	8,267	+1849.8%	Shares	Sole	2025-11-10
2025-06-30	$330,520	424	+48.8%	Shares	Sole	2025-08-12
2025-03-31	$235,384	285	-98.0%	Shares	Sole	2025-05-09
2020-09-30	$2,072,280	14,000	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.